(Q41028215)

https://api.crossref.org/works/10.1128/AAC.2.4.245

25 September 2017

Susceptibility of Mycobacteria to Rifampin (English)

1 reference

19 February 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.2.4.245

19 February 2023

author name string

C. L. Woodley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4670494

19 February 2023

J. O. Kilburn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4670494

19 February 2023

H. L. David

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4670494

19 February 2023

V. A. Silcox

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4670494

19 February 2023

language of work or name

English

0 references

publication date

1 October 1972

1 reference

PMC publication ID

444300

full work available at URL

25 September 2017

https://europepmc.org/articles/PMC444300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4670494

https://europepmc.org/articles/PMC444300?pdf=render

19 February 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4670494

https://journals.asm.org/doi/pdf/10.1128/AAC.2.4.245

19 February 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.2.4.245

Antimicrobial Agents and Chemotherapy

19 February 2023

published in

1 reference

25 September 2017

2

1 reference

25 September 2017

4

1 reference

25 September 2017

245-249

1 reference

Mutations of Bacteria from Virus Sensitivity to Virus Resistance

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

A Factor (or Mutator Gene) Influencing Mutation Rates in Escherichia Coli

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

Mutation and Adaptation of Phytomonas stewartii.

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

INDUCIBLE RESISTANCE TO ERYTHROMYCIN IN STAPHYLOCOCCUS AUREUS

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

NEW TYPE OF STREPTOMYCIN RESISTANCE RESULTING FROM ACTION OF THE EPISOMELIKE MUTATOR FACTOR IN ESCHERICHIA COLI

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

Antimycobacterial activity of rifampin under in vitro and simulated in vivo conditions

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

In Vitro Effect of Rifampin on Mycobacteria

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

Mechanism of Action of Rifampin on Mycobacterium smegmatis

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

Extrachromosomal inheritance in bacteria

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

A strain of Escherichia coli with an unusually high rate of auxotrophic mutation

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

Some observations on the genetics of isoniazid resistance in the tubercle bacilli

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

In vitro activity of rifampin against the H37RV strain of Mycobacterium tuberculosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

The antimycobacterial activity of rifampin

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

The susceptibility of mycobacteria to rifamide and rifampicin.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

Rifampin: in vitro effect on atypical mycobacteria

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444300

Selective mechanisms in bacteria

19 August 2018

1 reference

12 December 2020

Experimental observations on the antimycobacterial activity of rifampin

1 reference

12 December 2020

Action of rifamycin on RNA-polymerase from sensitive and resistant bacteria

1 reference

12 December 2020

Development of resistance of tuberculous bacteriae to antibacterial drugs during the course of in vitro passages

1 reference

12 December 2020

Inhibition by fifampin of mycobacteriophage D29 replication in its drug-resistant host, Mycobacterium smergmatis ATCC 607

1 reference

12 December 2020

The specific inhibition of the DNA-directed RNA synthesis by rifamycin

1 reference

12 December 2020

The effect of pulsed exposures to rifampin on the uptake of uridine- 14 C by Mycobacterium tuberculosis

1 reference

12 December 2020

In vitro susceptibility of mycobacteria to rifampin

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.2.4.245

1 reference

25 September 2017

1 reference

PMC publication ID

444300

25 September 2017

1 reference

PMC publication ID

444300